Procter & Gamble's Prices, China's Population, and More
In this podcast, Motley Fool senior analyst Bill Mann discusses:
Motley Fool senior analyst Sanmeet Deo talks with Dexcom CEO Kevin Sayer about his company's work in continuous glucose monitors and a major shift affecting the future of healthcare.
To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. To get started investing, check out our quick-start guide to investing in stocks. A full transcript follows the video.
Source Fool.com
